Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

CCL3 protects mice from corneal pathology during recurrent HSV-1 infection.

Stuart PM, Morris JE, Sidhu M, Keadle TL.

Front Biosci. 2008 May 1;13:4407-15.

PMID:
18508519
2.

[Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].

Shimomura Y.

Nippon Ganka Gakkai Zasshi. 2008 Mar;112(3):247-64; discussion 265. Review. Japanese.

PMID:
18411713
3.

Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions.

Twardy BS, Channappanavar R, Suvas S.

Invest Ophthalmol Vis Sci. 2011 Nov 4;52(12):8604-13. doi: 10.1167/iovs.11-8089.

4.

Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis.

Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, Lausch RN.

J Virol. 1998 May;72(5):3705-10.

5.

Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons.

van Gelderen BE, Van der Lelij A, Treffers WF, van der Gaag R.

Br J Ophthalmol. 2000 Nov;84(11):1238-43.

6.

A critical role for CCL2 and CCL3 chemokines in the regulation of polymorphonuclear neutrophils recruitment during corneal infection in mice.

Xue ML, Thakur A, Cole N, Lloyd A, Stapleton F, Wakefield D, Willcox MD.

Immunol Cell Biol. 2007 Oct;85(7):525-31. Epub 2007 Jun 19.

PMID:
17579602
7.

CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.

Srivastava R, Khan AA, Chilukuri S, Syed SA, Tran TT, Furness J, Bahraoui E, BenMohamed L.

J Virol. 2017 Jun 26;91(14). pii: e00278-17. doi: 10.1128/JVI.00278-17. Print 2017 Jul 15.

8.

Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice.

Komatsu K, Miyazaki D, Morohoshi K, Kuo CH, Kakimaru-Hasegawa A, Komatsu N, Namba S, Haino M, Matsushima K, Inoue Y.

Curr Eye Res. 2008 Sep;33(9):736-49. doi: 10.1080/02713680802344716.

PMID:
18798077
9.

Recurrent herpetic stromal keratitis in mice, a model for studying human HSK.

Morris J, Stuart PM, Rogge M, Potter C, Gupta N, Yin XT.

J Vis Exp. 2012 Dec 18;(70):e4276. doi: 10.3791/4276.

10.

CXCL9 compensates for the absence of CXCL10 during recurrent Herpetic stromal keratitis.

Tajfirouz D, West DM, Yin XT, Potter CA, Klein R, Stuart PM.

Virology. 2017 Jun;506:7-13. doi: 10.1016/j.virol.2017.02.022. Epub 2017 Mar 7.

11.

Recurrent herpetic stromal keratitis in mice: a model for studying human HSK.

Stuart PM, Keadle TL.

Clin Dev Immunol. 2012;2012:728480. doi: 10.1155/2012/728480. Epub 2012 Apr 23. Review.

12.

CD4(+) and CD8(+) cells are key participants in the development of recurrent herpetic stromal keratitis in mice.

Keadle TL, Morris JL, Pepose JS, Stuart PM.

Microb Pathog. 2002 Jun;32(6):255-62.

PMID:
12137752
13.

Interferon gamma is not required for recurrent herpetic stromal keratitis.

Keadle TL, Alexander DE, Leib DA, Stuart PM.

Virology. 2008 Oct 10;380(1):46-51. doi: 10.1016/j.virol.2008.07.018. Epub 2008 Aug 27.

14.

High-Risk Corneal Graft Rejection in the Setting of Previous Corneal Herpes Simplex Virus (HSV)-1 Infection.

Kuffova L, Knickelbein JE, Yu T, Medina C, Amescua G, Rowe AM, Hendricks RL, Forrester JV.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1578-87. doi: 10.1167/iovs.15-17894.

15.

CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.

West DM, Del Rosso CR, Yin XT, Stuart PM.

J Immunol. 2014 Feb 15;192(4):1762-7. doi: 10.4049/jimmunol.1302957. Epub 2014 Jan 17.

16.

[Cytokine expression in murine cornea tissue during recurrent herpetic stromal keratitis].

Xia LK, Zhang JS, Chen XL, Wang AY.

Zhonghua Yan Ke Za Zhi. 2005 May;41(5):403-8. Chinese.

PMID:
15938803
17.

Reversible nerve damage and corneal pathology in murine herpes simplex stromal keratitis.

Yun H, Rowe AM, Lathrop KL, Harvey SA, Hendricks RL.

J Virol. 2014 Jul;88(14):7870-80. doi: 10.1128/JVI.01146-14. Epub 2014 Apr 30.

18.

Cytokine expression in murine corneas during recurrent herpetic stromal keratitis.

Keadle TL, Usui N, Laycock KA, Kumano Y, Pepose JS, Stuart PM.

Ocul Immunol Inflamm. 2001 Sep;9(3):193-205.

PMID:
11815888
19.

Understanding the Role of Chemokines and Cytokines in Experimental Models of Herpes Simplex Keratitis.

Azher TN, Yin XT, Stuart PM.

J Immunol Res. 2017;2017:7261980. doi: 10.1155/2017/7261980. Epub 2017 Apr 9. Review.

20.

Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.

Rowe AM, Yun H, Treat BR, Kinchington PR, Hendricks RL.

J Immunol. 2017 Feb 15;198(4):1706-1717. doi: 10.4049/jimmunol.1601310. Epub 2017 Jan 6.

Supplemental Content

Support Center